Endoscopic Ultrasound Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product (Needle, Endoscope, Ultrasound Probe, Accessories, Ultrasonic Processors), By Application (Gastrointestinal Cancer, Lung Cancer, Pancreaticobiliary Disease, others), By End-use (Hospitals & Clinics, Ambulatory Surgical Centers, Others), By Region and Competition, 2020-2030F

Market Overview

The Global Endoscopic Ultrasound Market, valued at USD 1.57 Billion in 2024, is projected to experience a CAGR of 7.40% to reach USD 2.41 Billion by 2030. Endoscopic Ultrasound (EUS) is a sophisticated medical imaging procedure that integrates conventional endoscopy with ultrasound technology, enabling detailed visualization of the gastrointestinal tract and adjacent structures for precise diagnostic and therapeutic applications. The market supporting this technology is primarily driven by the increasing global prevalence of gastrointestinal and pulmonary diseases, a growing demand for minimally invasive diagnostic and therapeutic interventions, and continuous technological advancements that enhance imaging resolution and procedural capabilities. According to the World Endoscopy Organization, in 2023, the World Endoscopy Organization International School of EUS (WISE) program trained 44 participants from 22 countries, underscoring ongoing efforts to expand global EUS expertise.

Despite these growth factors, a significant challenge impeding market expansion is the substantial cost associated with EUS equipment acquisition and maintenance. Furthermore, the limited availability of highly skilled endoscopists proficient in performing complex EUS procedures also presents a notable constraint to broader market penetration.

Key Market Drivers

The escalating global burden of gastrointestinal and pulmonary diseases represents a primary force propelling the endoscopic ultrasound market. EUS offers critical capabilities for the early detection, accurate staging, and effective management of numerous conditions, including various cancers. For instance, according to "Global, regional and national burden of pancreatic cancer and its attributable risk factors from 2019 to 2021, with projection to 2044" published in Frontiers, in January 2025, the global incidence of pancreatic cancer increased to 508,533 cases in 2021, reflecting a 3.8% rise in incidence over the preceding two years. Such epidemiological trends underscore the increasing diagnostic and therapeutic need that EUS addresses. Concurrently, continuous advancements in endoscopic ultrasound technology significantly enhance the precision and utility of these systems. These innovations improve imaging resolution, expand therapeutic applications, and streamline procedural workflows. For example, according to "Fujifilm Unveils Premium Endoscopic Ultrasound Innovations at the American College of Gastroenterology's 2022 Annual Scientific Meeting" by GlobeNewswire, in October 2022, FUJIFILM Healthcare Americas Corporation obtained 510k clearance for its new EG-740UT linear EUS scope, designed for advanced diagnostic and therapeutic procedures. Such technological enhancements directly translate into improved patient outcomes and broader clinical adoption, directly influencing market expansion.

These drivers collectively contribute to the growing demand for skilled practitioners and advanced EUS equipment. The focus on developing expertise is evident in professional guidelines. According to the "Curriculum for diagnostic endoscopic ultrasound training in Europe: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement" published in Endoscopy, in December 2023, the ESGE recommended that trainees complete a minimum of 250 supervised EUS procedures to achieve proficiency in diagnostic EUS. This commitment to rigorous training further facilitates the market's growth by ensuring a competent workforce capable of utilizing complex EUS technologies.

Download Free Sample Report

Key Market Challenges

The limited availability of highly skilled endoscopists represents a significant impediment to the expansion of the global endoscopic ultrasound market. EUS procedures are technically demanding, requiring specialized training and extensive experience to perform effectively and safely. This scarcity of proficient practitioners restricts the volume of procedures that can be undertaken, particularly in emerging markets and regions with less developed healthcare infrastructure. The substantial investment in time and resources required to train endoscopists to a high level of EUS competency slows the rate at which new services can be introduced or existing ones can be scaled. For example, according to a World Gastroenterology Organisation report, in 2023, one of its training centers in San Jose provided advanced endoscopy courses to 298 doctors, underscoring the intensive and ongoing nature of skill development efforts. This directly curtails the wider adoption of EUS technology and limits its market penetration, hindering the potential for growth driven by demand for minimally invasive interventions and continued technological advancements.

Key Market Trends

Two prominent and distinct trends are significantly influencing the Global Endoscopic Ultrasound Market. The first is the increasing integration of Artificial Intelligence and IoT into EUS platforms, transforming diagnostic accuracy and procedural efficiency. AI algorithms are being developed to enhance image interpretation, assist in lesion detection, and provide real-time guidance during EUS interventions, thereby contributing to more precise and consistent diagnostic outcomes. In 2023, the American Society for Gastrointestinal Endoscopy (ASGE) formed an AI Task Force to develop governance frameworks for AI in healthcare, underscoring the formal recognition and strategic planning for AI's expanding role in advanced endoscopic procedures, including EUS. This technological evolution is further exemplified by Olympus Corporation's commercial launch of its OLYSENSE CAD/AI portfolio in the United States and European markets in September 2025, which received FDA 510(k) clearance and CE Mark certification in July 2024 for computer-aided polyp detection and diagnosis. Olympus also demonstrated its OLYSENSE platform alongside the EU-ME3 ultrasound processor, designed for EUS equipment, in May 2025, highlighting the connection between AI platforms and advanced endosonography.

The second significant trend is the continuous innovation in EUS-guided biopsy and aspiration devices, which is critical for accurate tissue acquisition and subsequent patient management. These advancements focus on improving needle design, enhancing tissue yield, and increasing the diagnostic accuracy for various lesions. The European Society of Gastrointestinal Endoscopy (ESGE), in its March 2024 (published online December 2023) Position Statement on the curriculum for diagnostic EUS training in Europe, recommended that trainees perform a minimum of 75 EUS-guided fine-needle aspiration/biopsies (EUS-FNA/FNBs) to achieve competence, particularly for pancreaticobiliary lesions. This numerical benchmark reflects the increasing volume and complexity of these crucial tissue sampling procedures. Furthermore, in July 2023, Cook Medical introduced its EchoTip ProCore, a high-resolution ultrasound biopsy needle designed to enable clinicians to obtain larger tissue samples from difficult-to-reach areas through minimally invasive EUS procedures, illustrating ongoing device innovation in this segment.

Segmental Insights

The Endoscope segment represents a significantly expanding component within the Global Endoscopic Ultrasound Market, driven by continuous technological advancements. Improvements in imaging capabilities, such as high-definition visualization and enhanced transducers, considerably boost diagnostic accuracy and procedural efficiency. This growth is further propelled by the increasing prevalence of various gastrointestinal and pancreatic diseases, alongside a rising demand for minimally invasive diagnostic and therapeutic procedures, including tumor staging and fine-needle aspirations. These factors collectively underscore the critical role and sustained expansion of endoscopes in modern medical diagnostics.

Regional Insights

North America leads the global Endoscopic Ultrasound Market, driven by its well-established healthcare infrastructure and high adoption rate of advanced medical technologies. The region benefits from significant investments in research and development by both government and leading companies, fostering continuous innovation in endoscopic ultrasound technology. Favorable reimbursement policies further support the widespread utilization of these advanced diagnostic and therapeutic procedures. Additionally, the clear regulatory frameworks established by bodies such as the U. S. Food and Drug Administration (FDA) ensure product safety and efficacy, promoting confidence among healthcare providers and patients alike. This combination of factors underpins North America's strong market position.

Recent Developments

• In May 2025, Olympus demonstrated its new AI Endoscopy Solution at DDW®, which included the newly launched EU-ME3 ultrasound processor. This compact ultrasound processor is specifically designed for use with Olympus' endoscopic and endobronchial ultrasound (EUS and EBUS) equipment, aiming for seamless integration with conventional endoscopy on a single workstation. The EU-ME3 offers high-resolution imaging and a display for clear visualization, supporting the detection and characterization of lesions. Advanced features like Contrast Harmonic Echo (CHE) and Shear Wave Quantification (SWQ) are incorporated to advance endosonography.

• In June 2024, EndoSound Inc. achieved a significant market milestone as the Centers for Medicare & Medicaid Services (CMS) granted a Transitional Pass-Through (TPT) code for its EndoSound Vision System™ (EVS™). Effective July 1, 2024, this code represents a crucial advancement for the revolutionary endoscopic ultrasound (EUS) technology. The CMS TPT status is instrumental in facilitating broader access and reimbursement for the EVS, which is designed to improve diagnostic capabilities in gastrointestinal procedures. This development supports the commercial rollout and adoption of the EVS in the healthcare market.

• In January 2024, EndoSound Inc., a medical technology company, received 510(k) clearance from the FDA for its novel EndoSound Vision System™ (EVS™). This breakthrough innovation in endoscopic ultrasound (EUS) technology follows the system's FDA Breakthrough Device designation, highlighting its potential to enhance patient care and accessibility. The EVS is designed to integrate with existing upper gastrointestinal endoscopes, offering a more economical EUS solution. Its controlled market release was scheduled for early in the first quarter of 2024, aiming to shift care to more efficient settings.

• In January 2024, Canon Medical Systems Corporation and Olympus Corporation announced a business alliance focused on Endoscopic Ultrasound Systems. Under this agreement, Canon Medical will be responsible for developing and manufacturing diagnostic ultrasound systems utilized in Endoscopic Ultrasonography (EUS). Olympus will manage the sales and marketing efforts for these systems. The collaboration integrates Canon's Aplio i800 diagnostic ultrasound system with Olympus' Ultrasound Endoscope, intending to deliver advanced EUS equipment that provides high-quality image diagnoses. The initiative targets global expansion, beginning with markets in Japan and Europe.

Key Market Players

• Boston Scientific Corporation
• Medtronic Plc.
• ConMed Corp.
• Olympus Corporation
• STERIS
• SonoScape Medical Corp.
• PENTEX Medical
• FUJIFILM Corporation
• Cook Group Incorporated

Report Scope:

In this report, the Global Endoscopic Ultrasound Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Endoscopic Ultrasound Market, By Product:

• Endoscopic Ultrasound Market, By Application:

• Endoscopic Ultrasound Market, By End-Use:

• Endoscopic Ultrasound Market, By Region:

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Endoscopic Ultrasound Market.

Available Customizations:

Global Endoscopic Ultrasound Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Global Endoscopic Ultrasound Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]